Heterocyclic compounds and uses thereof
US9840503B2 · kind B2 · utility
15Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 2016 |
| Grant date | Dec 12, 2017 |
| Priority date | — |
| Expiry date | May 10, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to heterocyclic compounds, and pharmaceutical compositions of the same, that are inhibitors of the TAM protein kinases and are useful in the treatment of TAM-associated diseases such as cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.